Literature DB >> 8808687

Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells.

R Das1, B K Vonderhaar.   

Abstract

The peptide hormone prolactin (Prl) regulates proliferation of normal and malignant mammary cells. In the present study we demonstrate that two Prl responsive cell lines, NOG-8 and T47D, activate the JAK2-SHC-MAPK pathway in a rapid and transient manner. Within 1 min of Prl treatment there was an increase in association of JAK2 with SHC, followed by rapid phosphorylation of both the 52 kDa and 46 kDa SHC proteins. Grb2 and Sos associated with the SHC proteins within 1-3 min of Prl treatment in these mammary cells. Within 5 min of hormone treatment we observe an increase in ras-GTP suggesting activation of ras. We also showed a rapid and transient tyrosine phosphorylation of STAT5 in proliferating T47D cells which reached its peak after 30 min of Prl treatment. These results indicate that Prl receptors, after binding the ligand, activate several pathways for signal transduction leading to mitogenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8808687

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  A pathway map of prolactin signaling.

Authors:  Aneesha Radhakrishnan; Rajesh Raju; Nirvana Tuladhar; Tejaswini Subbannayya; Joji Kurian Thomas; Renu Goel; Deepthi Telikicherla; Shyam Mohan Palapetta; B Abdul Rahiman; Desai Dattatraya Venkatesh; Kulkarni-Kale Urmila; H C Harsha; Premendu Prakash Mathur; T S Keshava Prasad; Akhilesh Pandey; Carrie Shemanko; Aditi Chatterjee
Journal:  J Cell Commun Signal       Date:  2012-06-09       Impact factor: 5.782

2.  Adapter protein SH2B1beta binds filamin A to regulate prolactin-dependent cytoskeletal reorganization and cell motility.

Authors:  Leah Rider; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2011-05-12

3.  Identification of NEK3 Kinase Threonine 165 as a Novel Regulatory Phosphorylation Site That Modulates Focal Adhesion Remodeling Necessary for Breast Cancer Cell Migration.

Authors:  Katherine M Harrington; Charles V Clevenger
Journal:  J Biol Chem       Date:  2016-08-03       Impact factor: 5.157

4.  Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.

Authors:  Kathryn G Schuff; Shane T Hentges; Michele A Kelly; Nadine Binart; Paul A Kelly; P Michael Iuvone; Sylvia L Asa; Malcolm J Low
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Two independent histidines, one in human prolactin and one in its receptor, are critical for pH-dependent receptor recognition and activation.

Authors:  Mandar V Kulkarni; M Cristina Tettamanzi; James W Murphy; Camille Keeler; David G Myszka; Naomi E Chayen; Elias J Lolis; Michael E Hodsdon
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

Review 6.  Prolactin as a mitogen in mammary cells.

Authors:  R Das; B K Vonderhaar
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

Review 7.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

8.  Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos.

Authors:  Jennifer H Gutzman; Sarah E Nikolai; Debra E Rugowski; Jyoti J Watters; Linda A Schuler
Journal:  Mol Endocrinol       Date:  2005-03-03

9.  Tyrosyl phosphorylated PAK1 regulates breast cancer cell motility in response to prolactin through filamin A.

Authors:  Alan Hammer; Leah Rider; Peter Oladimeji; Leslie Cook; Quanwen Li; Raymond R Mattingly; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2013-01-22

Review 10.  Prolactin regulation of mammary gland development.

Authors:  Samantha R Oakes; Renee L Rogers; Matthew J Naylor; Christopher J Ormandy
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.